* Oral ergotamine or intravenous dihydroergotamine may be used as an alternative agent for patients who are unable to tolerate triptans and those with prior attacks that were refractory to triptans. However, ergots should not be given to patients who have received a triptan within the preceding 24 hours due to the risk of arterial vasoconstriction. Refer to UpToDate topic for additional details.
¶ Intranasal administration of triptans should be in a single nostril contralateral to the side of the cluster headache because patients frequently have rhinorrhea and nasal stuffiness ipsilateral to the headache.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟